Mounting studies have indicated that several immune infiltrating cells are conducive to the favorable prognosis of patients with ovarian cancer, especially CD8+T cells, CD4+T cells, and natural killer cells [44–46]. The gene discussed is CD4; the disease is ovarian carcinoma.